$FBIO News Article - Journey Medical Corporation A
Post# of 122
(Total Views: 238)
Posted On: 03/17/2022 1:45:50 PM
$FBIO News Article - Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea https://marketwirenews.com/news-releases/jour...31763.html
(0)
(0)Fortress Biotech, Inc. (FBIO) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼